celecoxib and 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid

celecoxib has been researched along with 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Geis, GS; Hubbard, RC; Isakson, PC; Karim, A; Leese, PT; Yu, SS1

Trials

1 trial(s) available for celecoxib and 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid

ArticleYear
Effects of celecoxib, a novel cyclooxygenase-2 inhibitor, on platelet function in healthy adults: a randomized, controlled trial.
    Journal of clinical pharmacology, 2000, Volume: 40, Issue:2

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Bleeding Time; Blood Platelets; Celecoxib; Collagen; Cyclooxygenase Inhibitors; Double-Blind Method; Female; Humans; Male; Middle Aged; Platelet Aggregation; Pyrazoles; Sulfonamides; Thromboxane B2

2000